Immune Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Octagam 10% Approved

The FDA has approved Octagam 10% liquid preparation for the treatment of adults with chronic immune thrombocytopenic purpura (ITP).

New Drug Product: Sylvant

Multicentric Castleman’s disease (MCD) in adults who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.

Sjӧgren's Syndrome and MI Risk

A significant increase in the risk of heart attack was seen I patients with Sjӧgren's syndrome (SjS), especially in the first year following diagnosis.

Avoiding Flare Trigger in Lupus

New research showed that it is possible to successfully stop immunosuppressant therapy without triggering a flare for the majority of lupus patients in remission.

Alcohol Binging and the Immune System

A new study showed that a single episode of binge drinking can cause bacteria leakage from the gut and increase levels of endotoxins in the ...

Multicentric Castleman's Disease Drug

Janssen Biotech announced that the FDA has approved Sylvant (siltuximab) for the treatment of patients with multicentric Castleman's disease (MCD).

Chart: Hematological Values

Review this chart on Hematological Reference Values for quick information when you need it.

Earn CME/CE Credits

With this certified-for-credit activity, review cases including "A collaborative approach to myasthenia gravis."

Featured courses from mycme

Presented by Brigham and Women's Hospital and OakstoneExternal web site

Prepares attendees for the ABIM Subspecialty Board Examination in Critical Care (Certification/Re-Certification). Conveys state-of-the-art information ...

CME 27.00 Credits

Transformative Changes in the Management of Multiple MyelomaExternal web site

This symposium will address practical applications of an individualized approach to management of patients with ...

CME 0.50 Credits

Sign Up for Free e-newsletters